Sectoral Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695K | Hold |
16,085
| – | – | 0.46% | 58 |
|
|
2025
Q1 | $556K | Buy |
16,085
+4,585
| +40% | +$159K | 0.43% | 52 |
|
|
2024
Q4 | $316K | Sell |
11,500
-3,585
| -24% | -$98.4K | 0.21% | 64 |
|
|
2024
Q3 | $384K | Sell |
15,085
-450
| -3% | -$11.5K | 0.23% | 67 |
|
|
2024
Q2 | $394K | Sell |
15,535
-570
| -4% | -$14.4K | 0.16% | 74 |
|
|
2024
Q1 | $498K | Buy |
16,105
+3,150
| +24% | +$97.4K | 0.2% | 71 |
|
|
2023
Q4 | $523K | Sell |
12,955
-167,240
| -93% | -$6.75M | 0.23% | 77 |
|
|
2023
Q3 | $4.75M | Buy |
+180,195
| New | +$4.75M | 0.93% | 46 |
|
|
2022
Q1 | – | Sell |
-282,950
| Closed | -$4.72M | – | 109 |
|
|
2021
Q4 | $4.72M | Sell |
282,950
-190,000
| -40% | -$3.17M | 0.71% | 55 |
|
|
2021
Q3 | $22.2M | Buy |
472,950
+147,100
| +45% | +$6.89M | 1.84% | 12 |
|
|
2021
Q2 | $19.9M | Buy |
325,850
+142,750
| +78% | +$8.7M | 1.61% | 19 |
|
|
2021
Q1 | $11.3M | Buy |
183,100
+177,100
| +2,952% | +$10.9M | 0.86% | 49 |
|
|
2020
Q4 | $427K | Buy |
+6,000
| New | +$427K | 0.03% | 94 |
|